These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28239182)

  • 21. Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis?
    Patrizi A; Venturi M; Scorzoni R; Pazzaglia M; Malavolta N; Bardazzi F
    G Ital Dermatol Venereol; 2014 Apr; 149(2):177-84. PubMed ID: 24819637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective data collection of psoriasis treatment with fumaric acid esters in children and adolescents in Germany (KIDS FUTURE study).
    Reich K; Hartl C; Gambichler T; Zschocke I
    J Dtsch Dermatol Ges; 2016 Jan; 14(1):50-8. PubMed ID: 26713639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childhood psoriasis: a study of 137 cases from central China.
    Wu Y; Lin Y; Liu HJ; Huang CZ; Feng AP; Li JW
    World J Pediatr; 2010 Aug; 6(3):260-4. PubMed ID: 20549408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newer trends in the management of psoriasis at difficult to treat locations: scalp, palmoplantar disease and nails.
    Handa S
    Indian J Dermatol Venereol Leprol; 2010; 76(6):634-44. PubMed ID: 21079306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and management of nail psoriasis].
    Sánchez-Regaña M; Umbert P
    Actas Dermosifiliogr; 2008; 99(1):34-43. PubMed ID: 18206085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pattern and clinical characteristics of patients with nail psoriasis in Sarawak General Hospital, Malaysia.
    Yap FB; Pubalan M
    Indian J Dermatol Venereol Leprol; 2010; 76(6):703-4. PubMed ID: 21079320
    [No Abstract]   [Full Text] [Related]  

  • 27. [Children with psoriasis in secondary care: Clinical aspects and comorbidities diverge from the generally published data].
    Mahé E; Maccari F; Ruer-Mulard M; Bodak N; Barthelemy H; Nicolas C; Pépin E; Pillette-Delarue M; Buzenet C; Delaire PL; Nadaud M; Bouscarat F; Drouot-Lhoumeau D; Lepelley-Dupont C; Acher A; Beauchet A; Corgibet F;
    Ann Dermatol Venereol; 2019 May; 146(5):354-362. PubMed ID: 30954294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics of patients with facial psoriasis in Malaysia.
    Syed Nong Chek SR; Robinson S; Mohd Affandi A; Baharum N
    Int J Dermatol; 2016 Oct; 55(10):1092-5. PubMed ID: 27061170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The burden of nail psoriasis: an introduction.
    Baran R
    Dermatology; 2010; 221 Suppl 1():1-5. PubMed ID: 20733309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marked improvement in nail psoriasis during treatment with adalimumab.
    Irla N; Yawalkar N
    Dermatology; 2009; 219(4):353-6. PubMed ID: 19851059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nail psoriasis: treatment with tazarotene 0.1% hydrophilic ointment.
    Fischer-Levancini C; Sánchez-Regaña M; Llambí F; Collgros H; Expósito-Serrano V; Umbert-Millet P
    Actas Dermosifiliogr; 2012 Oct; 103(8):725-8. PubMed ID: 22818395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of nail psoriasis: best practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Crowley JJ; Weinberg JM; Wu JJ; Robertson AD; Van Voorhees AS;
    JAMA Dermatol; 2015 Jan; 151(1):87-94. PubMed ID: 25471223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interventions for nail psoriasis.
    de Vries AC; Bogaards NA; Hooft L; Velema M; Pasch M; Lebwohl M; Spuls PI
    Cochrane Database Syst Rev; 2013 Jan; (1):CD007633. PubMed ID: 23440816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
    Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
    J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular findings in patients with psoriasis.
    Kilic B; Dogan U; Parlak AH; Goksugur N; Polat M; Serin D; Ozmen S
    Int J Dermatol; 2013 May; 52(5):554-9. PubMed ID: 23330957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Psoriasis in Children and Adolescents in the United States: A Claims-Based Analysis.
    Paller AS; Singh R; Cloutier M; Gauthier-Loiselle M; Emond B; Guérin A; Ganguli A
    J Drugs Dermatol; 2018 Feb; 17(2):187-194. PubMed ID: 29462227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psoriasis among Sarawakian natives in a tertiary skin centre in Sarawak.
    Yap FB
    Australas J Dermatol; 2010 Aug; 51(3):210-1. PubMed ID: 20695864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A survey of childhood psoriasis in Kuwait.
    al-Fouzan AS; Nanda A
    Pediatr Dermatol; 1994 Jun; 11(2):116-9. PubMed ID: 8041649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Periungual pyogenic granulomas due to topical tazarotene for nail psoriasis.
    Piraccini BM; Venturi M; Patrizi A
    G Ital Dermatol Venereol; 2014 Jun; 149(3):363-6. PubMed ID: 24819765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric psoriasis.
    Busch AL; Landau JM; Moody MN; Goldberg LH
    Skin Therapy Lett; 2012 Jan; 17(1):5-7. PubMed ID: 22358228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.